National Heart, Lung, and Blood Institute; Notice of Meeting, 49561 [2018-21371]
Download as PDF
<![CDATA[
49561
Federal Register / Vol. 83, No. 191 / Tuesday, October 2, 2018 / Notices
requesting information, please include
the document identifier 0990–New–60D
and project title for reference, to
Sherrette.funn@hhs.gov, or call the
Reports Clearance Officer, (202) 795–
7714.
SUPPLEMENTARY INFORMATION: Interested
persons are invited to send comments
regarding this burden estimate or any
other aspect of this collection of
information, including any of the
following subjects: (1) The necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions; (2) the accuracy
of the estimated burden; (3) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(4) the use of automated collection
techniques or other forms of information
technology to minimize the information
collection burden.
Title of the Collection: Cohort 3 Teen
Pregnancy Prevention (TPP) Program
Performance Measures.
Type of Collection: New.
OMB No. 0990–NEW—Office of
Adolescent Health, OS.
Abstract: The Office of Adolescent
Health Requests a new clearance for the
collection of performance measures
from the cohort 3 Teen Pregnancy
Prevention (TPP) grant recipients,
anticipated to be awarded in September
2018. OAH released a funding
announcement to support Phase 1 of a
third cohort of TPP grantees in the
spring of 2018, subject to the availability
of funding, with awards expected to be
made in September 2018. Phase 1 cohort
3 TPP grants shall be issued in for an
anticipated 2 year period of
performance. A subset of successful
Phase 1 grantees will be selected for
Phase 2 grants. A 3 year clearance is
requested for this request. TPP phase 1
grant recipients will be expected to
report data twice each year.
ANNUALIZED BURDEN HOUR TABLE
TPP Grantees, Performance Measures Form.
TPP Participants Pre/Post Test
Compilation.
TPP Participants Pre/Post Test ........
Grant Recipients ..............................
60
2
7
840
Grant Recipients ..............................
60
2
3
360
Participants in TPP-grant funded
projects.
45,000
2
5/60
7,500
...........................................................
........................
2
........................
8,700
Terry Clark,
Office of the Secretary, Asst. Paperwork
Reduction Act Reports Clearance Office.
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
[FR Doc. 2018–21402 Filed 10–1–18; 8:45 am]
BILLING CODE 4168–11–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Meeting
amozie on DSK3GDR082PROD with NOTICES1
Average
burden per
response
Respondents
(if necessary)
Total ...........................................
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Heart, Lung,
and Blood Advisory Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
VerDate Sep<11>2014
18:39 Oct 01, 2018
Jkt 247001
Number of
respondents
Number of
responses per
respondents
Forms
(if necessary)
Name of Committee: National Heart, Lung,
and Blood Advisory Council.
Date: October 30, 2018.
Open: 8:00 a.m. to 12:00 p.m.
Agenda: To discuss program policies and
issues.
Place: National Institutes of Health, Porter
Neuroscience Research Center, Building 35A
Convent Drive, Bethesda, MD 20892.
Closed: 12:30 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Porter
Neuroscience Research Center, Building 35A
Convent Drive, Bethesda, MD 20892.
Contact Person: Laura K. Moen, Ph.D.,
Director, Division of Extramural Research
Activities National Heart, Lung, and Blood
Institute, National Institutes of Health, 6701
Rockledge Drive, Room 7100, Bethesda, MD
20892, 301–435–0260, moenl@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
Total burden
hours
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page:
www.nhlbi.nih.gov/meetings/nhlbac/
index.htm, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: September 26, 2018.
Ronald J. Livingston, Jr.,
Program Analyst Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–21371 Filed 10–1–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Charter Renewal
In accordance with Title 41 of the
U.S. Code of Federal Regulations,
Section 102–3.65(a), notice is hereby
given that the Charter for the National
Cancer Institute Council of Research
Advocates was renewed for an
E:\FR\FM\02OCN1.SGM
02OCN1
]]>Agencies
[Federal Register Volume 83, Number 191 (Tuesday, October 2, 2018)]
[Notices]
[Page 49561]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-21371]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Heart,
Lung, and Blood Advisory Council.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Heart, Lung, and Blood Advisory
Council.
Date: October 30, 2018.
Open: 8:00 a.m. to 12:00 p.m.
Agenda: To discuss program policies and issues.
Place: National Institutes of Health, Porter Neuroscience
Research Center, Building 35A Convent Drive, Bethesda, MD 20892.
Closed: 12:30 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Porter Neuroscience
Research Center, Building 35A Convent Drive, Bethesda, MD 20892.
Contact Person: Laura K. Moen, Ph.D., Director, Division of
Extramural Research Activities National Heart, Lung, and Blood
Institute, National Institutes of Health, 6701 Rockledge Drive, Room
7100, Bethesda, MD 20892, 301-435-0260, [email protected].
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
Information is also available on the Institute's/Center's home
page: www.nhlbi.nih.gov/meetings/nhlbac/index.htm, where an agenda
and any additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Diseases and Resources Research, National Institutes of
Health, HHS)
Dated: September 26, 2018.
Ronald J. Livingston, Jr.,
Program Analyst Office of Federal Advisory Committee Policy.
[FR Doc. 2018-21371 Filed 10-1-18; 8:45 am]
BILLING CODE 4140-01-P
